Literature DB >> 14530553

Oral bisphosphonates in polyostotic fibrous dysplasia.

V V Khadilkar1, A V Khadilkar, G B Maskati.   

Abstract

The bisphosphonates inhibit osteoclastic bone resorption and have been used as an intravenous infusion in fibrous dysplasia of the bone. Oral bisphosphonates are cheaper and also easy to administer. We report a case of polyostotic fibrous dysplasia in a three-year-old child who showed significant improvement in bone mineral density after treatment with oral alendronate.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14530553

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


  7 in total

Review 1.  [Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects].

Authors:  Sigrun Egner-Höbarth; H Welkerling; R Windhager
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

2.  Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia.

Authors:  Ashu Rastogi; Sanjay Kumar Bhadada; Anil Bhansali
Journal:  Indian J Pediatr       Date:  2011-07-15       Impact factor: 1.967

3.  Polyostotic form of fibrous dysplasia in a 13 years old Colombian girl showing clinical and biochemical response to neridronate intravenous therapy.

Authors:  Edwin Jobany Parra Prada; Khodr Haidar Hassan; Maria Luisa Brandi; Alberto Falchetti
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

4.  Long-term efficacy of oral alendronate therapy in an elderly patient with polyostotic fibrous dysplasia: A case report.

Authors:  Gui-Dong Li; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Takashi Ariizumi; Yongjun Xu; Naoto Endo
Journal:  Oncol Lett       Date:  2011-08-02       Impact factor: 2.967

5.  Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia.

Authors:  Chiara Di Pede; Sabrina Congedi; Sara Rossin; Antuan Divisic; Alesandra De Gregorio; Caterina Agosto; Igor Catalano; Alessandro Mazza; Leonardo Sartori; Stefano Masiero; Franca Benini
Journal:  Case Rep Pediatr       Date:  2016-09-22

Review 6.  A review of skeletal dysplasia research in India.

Authors:  A Uttarilli; H Shah; A Shukla; K M Girisha
Journal:  J Postgrad Med       Date:  2018 Apr-Jun       Impact factor: 1.476

Review 7.  Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors:  Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal:  Br J Clin Pharmacol       Date:  2018-12-25       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.